Home › Funds › Pale Fire Capital SE › SNDX

Pale Fire Capital SE position in SNDX

SYNDAX PHARMACEUTICALS INC · Health Care

Pale Fire Capital SE reported holding 33,845 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$636K, representing 0.05% of its reported portfolio and ranking #29 among its reported holdings. Pale Fire Capital SE has disclosed SNDX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)33.84K sh
Reported value held$636.29K
Portfolio Weight0.05%
First reportedQ4 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pale Fire Capital SE's SNDX position evolved

Pale Fire Capital SE first disclosed a stake in SNDX in Q4 2025 at 284,460 shares (US$6.0M). The position peaked in Q1 2026 at 284,460 shares, worth US$6.6M. Across 4 filings, Pale Fire Capital SE increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 33,845 shares valued at US$636K — a reduction of -91,705 shares quarter over quarter.. Notable position changes include a 56% trim in Q2 2026 (shares fell 14% over the following quarter), a 73% trim in Q3 2026 (shares fell 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 284.46K $5.98M New
Q1 2026 284.46K $6.64M Hold
Q2 2026 125.55K $2.74M Reduce
Q3 2026 33.84K $636.29K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SNDX and 13F data

SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SNDX

All SNDX fund holders →

FAQ

How long has Pale Fire Capital SE held SNDX?

Pale Fire Capital SE has disclosed SNDX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Pale Fire Capital SE's current position in SNDX?

As of Q3 2026, Pale Fire Capital SE holds 33.84K shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $636.29K, representing 0.05% of its reported portfolio and ranking #29.

Has Pale Fire Capital SE been buying or selling SNDX?

In the latest 13F filing (Q3 2026), Pale Fire Capital SE reduced its position in SNDX. The position peaked in Q1 2026 at 284.46K shares.

Which other funds hold SNDX?

Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.